2007
DOI: 10.1016/j.lfs.2007.01.041
|View full text |Cite
|
Sign up to set email alerts
|

Disruption of endothelial caveolae is associated with impairment of both NO- as well as EDHF in acetylcholine-induced relaxation depending on their relative contribution in different vascular beds

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
24
0

Year Published

2007
2007
2016
2016

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 27 publications
(25 citation statements)
references
References 48 publications
1
24
0
Order By: Relevance
“…On the other hand, in renal arteries and mesenteric arteries from normotensive rats treated with 1 mM CD, relaxation by SNP was not impaired (Xu et al, 2007). In the same way, in rabbit aorta treated with 2% 2-hydroxypropyl-␤-cyclodextrin relaxation by SNP was not impaired either (Darblade et al, 2001).…”
Section: Discussionmentioning
confidence: 88%
“…On the other hand, in renal arteries and mesenteric arteries from normotensive rats treated with 1 mM CD, relaxation by SNP was not impaired (Xu et al, 2007). In the same way, in rabbit aorta treated with 2% 2-hydroxypropyl-␤-cyclodextrin relaxation by SNP was not impaired either (Darblade et al, 2001).…”
Section: Discussionmentioning
confidence: 88%
“…Acetylcholine-induced relaxation has been shown to be decreased after membrane cholesterol depletion in different rat arteries [38,39], but either increased or not modified in systemic arteries isolated from…”
Section: Discussionmentioning
confidence: 99%
“…In addition to that, the area under each individual curve (AUC; in arbitrary units) was determined for ACh-induced relaxation (SigmaPlot version 10.0, Systat Software, San Jose, CA). The AUC was used to present total endothelium-dependent relaxation and for the subsequent analysis of differences in ACh-mediated relaxation with and without inhibitors present to estimate the contribution of the different EDRFs, i.e., PGs for the part sensitive to cycloxygenase inhibition with indomethacin, NO for the part sensitive to NOS inhibition with L-NMMA, and EDHF by means of exclusion of PG and NO (34). Data are presented as means Ϯ SE, and n refers to the number of animals in each group.…”
Section: Animalsmentioning
confidence: 99%
“…22). CAV-1, a structural protein within the caveolus, has been identified as a key regulator of eNOS activity (34). In a recent study (3), it was demonstrated that the scaffolding domain of CAV-1 acts as an endogenous negative regulator of eNOS function, thereby limiting basal NO release.…”
Section: H714 Vascular Effects Of Gdf15mentioning
confidence: 99%